Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Anterior spinal cord infarction with permanent paralysis following endoscopic ultrasound celiac plexus neurolysis
Fujii, Larissa L., Clain, J, Levy, Michael J. , Morris, Jonathan M.

Endoscopy | March 18, 2013 | Volume: 44 | Issue: S 02 | Pages: E265-E266

10.1055/s-0032-1309708 | PMID 22814912 Get It

Disseminated Mycobacterium haemophilum infection in a 72-year-old patient with rheumatoid arthritis on infliximab
Collins, C Scott, Terrell, Christine L., Mueller, Paul S.

BMJ Case Reports | March 16, 2013 | Volume: 2013 | Issue: No issue available | Pages: bcr2012008034

10.1136/bcr-2012-008034 | PMID 23505273 Get It

Mycobacterium haemophilum is a slow growing, aerobic, fastidious mycobacterium requiring hemin and a temperature of 30–32° C for optimal growth that is ubiquitous in nature. Disease in immunocompromised adults typically manifests as skin lesions such as papules, pustules and ulcerations. This organism also causes lymphadenitis in immunocompetent children. Antitumour necrosis factor-α (anti-TNF-α) therapy with agents such as infliximab, etanercept and adalimumab is increasingly being used for immunosuppression in patients with various autoimmune conditions. These agents are known to place patients at increased risk for tuberculosis and other granulomatous diseases. However, little is known about illness caused by M haemophilum in patients on immunosuppression with anti-TNF-α therapy. We describe a case of disseminated M haemophilum manifesting as skin lesions in a 72-year-old man with rheumatoid arthritis on infliximab and methotrexate.
Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting: Is There Any Benefit? A Systematic Review and Meta-Analysis
Shah, Ishan K., Altarabsheh, Salah E. , Erwin, Patricia J., Boilson, Barry A. , Park, Soon J., Joyce, Lyle D., Deo, Salil V. , Dunlay, Shannon M. , Altarabsheh, Salah

Journal of Cardiac Surgery | March 15, 2013 | Volume: 28 | Issue: 2 | Pages: 109-116

10.1111/jocs.12074 | PMID 23488578 Get It

Faculty Opinions recommendation of Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use.
Miller, Virginia M.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 15, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717985531.793472415 Get It

Surgical outcomes in recurrent glioma
Hoover, Jason M. , Nwojo, Macaulay, Puffer, Ross C. , Mandrekar, Jay , Meyer, Fredric B. , Parney, Ian F. , Parney, Ian F

Journal of Neurosurgery | March 15, 2013 | Volume: 118 | Issue: 6 | Pages: 1224-1231

10.3171/2013.2.jns121731 | PMID 23495879 Get It

Object The object of this study was to assess outcomes after surgery for recurrent intracranial glioma. Methods The authors retrospectively reviewed cases involving adult patients with intracranial glioma patients undergoing initial surgery (biopsy or resection) and one or more additional surgeries at their institution. Results A total of 323 operations were performed in 131 patients. The median survival was 76 months after first surgery, 36 months after second, 24 months after third, and 26.5 months after 4 or more surgeries. The overall complication rate was 12.8% after first surgery, 27.0% after second (OR 2.52, p = 0.0068), 22.0% after third (OR 1.92, not statistically significant [NS]), and 22.2% after 4 or more (OR 1.95, NS). Neurological complications occurred in 4.8% of patients at first surgery, 12.1% at second (OR 2.7, p = 0.0437), 8.2% at third (OR 1.75, NS), and 11.1% at 4 or more surgeries (OR 2.4583, NS). Regional complications occurred in 6.2% after first surgery, 9.9% after second surgery (OR 2.30, p = 0.095), 13.7% after third surgery (OR 3.31, p = 0.015), and 22.2% after 4 or more surgeries (OR 5.95, p = 0.056). Systemic complications occurred in 3.2% after first surgery, in 7.3% after second surgery (OR 2.3, p = 0.NS), in 4.1% after third surgery (OR 1.3, NS), and 0% after 4 or more surgeries. Reduction in Karnofsky Performance Status score occurred in 0% after first surgery, 8.1% after second surgery (OR 3.13, p = 0.0018), 10.2% after third surgery (OR 5.52, p < 0.0001), and 11.1% after 4 or more surgeries (OR 1.037, NS). Conclusions Postoperative survival is relatively prolonged but complication risk increases in patients with glioma who undergo multiple cranial surgeries. The largest increase in neurological risk occurs between the first and second surgery. In contrast, regional complication risk increases consistently with each surgery. The risk of systemic complications is not significantly altered with increasing surgeries. However, these complications only result in a modestly increased risk of functional decline after 2 or more surgeries. These findings may help counsel patients considering multiple glioma surgeries.
Faculty Opinions recommendation of Small-molecule activation of the TRAIL receptor DR5 in human cancer cells.
Kaufmann, Scott H. , Meng, Wei , Kaufmann, Scott H

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 15, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717988213.793472490 Get It

Faculty Opinions recommendation of TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer.
Kaufmann, Scott H. , Kaufmann, Scott H

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 15, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717988215.793472492 Get It

Coexisting Primary Hyperparathyroidism and Sarcoidosis Cause Increased Angiotensin-Converting Enzyme and Decreased Parathyroid Hormone and Phosphate Levels
Lim, Vivien, Clarke, B.L.

The Journal of Clinical Endocrinology & Metabolism | March 15, 2013 | Volume: 98 | Issue: 5 | Pages: 1939-1945

10.1210/jc.2012-4197 | PMID 23493435 Get It

HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines
Li, Jinping , Mariani, Andrea , Chen, Dong , Klatt, Edward, Podratz, Karl C. , Drapkin, Ronny , Broaddus, Russell R. , Dowdy, Sean C. , Jiang, Shi‐Wen , Chen, Hai-Bin , Chen, Haibin , Klatt, Edward, Chen, Dong , Drapkin, Ronny

International Journal of Molecular Sciences | March 15, 2013 | Volume: 14 | Issue: 3 | Pages: 6026-6043

10.3390/ijms14036026 | PMID 23502467 Get It

HE4, also known as WFDC2, is a useful biomarker for ovarian cancer when either used alone or in combination with CA125. HE4 is also overexpressed in endometrial cancer (EC), but its function in cancer cells is not clear. In this study, we investigate the role of HE4 in EC progression. An HE4-overexpression system was established by cloning the HE4 prototypic mRNA variant (HE4-V0) into a eukaryotic expression vector. Following transfection, stable clones in two EC cell lines were selected. The effects of HE4 overexpression on cell growth and function were measured with the use of cell proliferation assay, matrigel invasion, and soft agar gel colony formation assays. HE4-induced cancer cell proliferation in vivo was examined in a mouse xenograft model. HE4 overexpression significantly enhanced EC cell proliferation, matrigel invasion, and colony formation in soft agar. Moreover, HE4 overexpression promoted tumor growth in the mouse xenograft model. HE4 overexpression enhanced several malignant phenotypes in cell culture and in a mouse model. These results are consistent with our previous observation that high levels of serum HE4 closely correlate with the stage, myometrial invasion and tumor size in patients with EC. This study provides evidence that HE4 overexpression directly impacts tumor progression in endometrial cancer.
Natriuretic Peptide Receptor-3 Gene ( NPR3 )
Pereira, Naveen L. , Pelleymounter, Linda L., Moon, Irene, Stilling, Gail A., Eckloff, Bruce W., Wieben, Eric D. , Redfield, Margaret M. , Burnett, John C. , Yee, Vivien C., Weinshilboum, Richard M. , Lin, Dong , Weinshilboum, Richard M.

Circulation: Cardiovascular Genetics | March 15, 2013 | Volume: 6 | Issue: 2 | Pages: 201-210

10.1161/circgenetics.112.964742 | PMID 23493048 Get It

Background— The primary role of natriuretic peptide receptor-3 (NPR3) or NPR-C is in the clearance of natriuretic peptides that play an important role in modulating intravascular volume and vascular tone. Genetic variation in NPR3 has been associated with variation in blood pressure and obesity. Despite the importance of NPR3, sequence variation in the gene has not been addressed using DNA from different ethnic populations. We set out to identify and functionally characterize genetic variation in NPR3 in 3 ethnic groups. Methods and Results— DNA samples from 96 European American, 96 African American, and 96 Han Chinese American healthy subjects were used to resequence NPR3 exons, splice junctions, and flanking regions. We identified 105 polymorphisms, 50 of which were novel, including 8 nonsynonymous single-nucleotide polymorphisms, 7 were novel. Expression constructs were created for the nonsynonymous single-nucleotide polymorphisms. HEK293 cells were transfected with constructs for wild type and variant allozymes; and recombinant proteins were measured by quantitative Western blot analysis. The most significant change in NPR3 protein was observed for the Arg146 variant allozyme, with 20% of wild-type protein, primarily because of autophagy-dependent degradation. NPR3 structural modeling confirmed that the Arg146 variant protein was not compatible with wild-type conformation and could result in protein misfolding or instability. Conclusions— Multiple novel NPR3 genetic polymorphisms were identified in 3 ethnic groups. The Arg146 allozyme displayed a significant decrease in protein quantity because of degradation mediated predominantly by autophagy. This genetic variation could have a significant effect on the metabolism of natriuretic peptides with potential clinical implications.